Aaron L. Zelbolsky

University of Tennessee Health Science Center

Papers

1

Total Citations

7

H-Index

1

About

Aaron L. Zelbolsky is a clinician-researcher whose work sits at the intersection of surgical oncology and patient-centered outcomes, with a particular focus on human papillomavirus (HPV)-associated oropharynx cancer. His major contribution lies in advancing the evidence base for de-escalated treatment strategies—specifically, surgery alone—in this growing patient population. His most-cited work, a 2023 prospective study on quality of life outcomes after surgery alone for HPV-positive oropharynx cancer, has already garnered 7 citations, reflecting its timely relevance in a field increasingly concerned with balancing oncologic control and functional preservation. Zelbolsky’s research is notable for its rigorous prospective design and its emphasis on patient-reported outcomes, offering critical data that helps guide shared decision-making between clinicians and patients. By demonstrating that select patients can achieve favorable quality of life without adjuvant therapy, his work challenges traditional treatment paradigms and supports a shift toward less morbid care. For students and researchers, Zelbolsky’s profile exemplifies how thoughtful, outcomes-driven research can directly shape clinical practice in head and neck oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Tennessee Health Science Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago